Summary Nitric oxide (NO). an endogenous free radical, has been implicated in a wide range of biological functions. NO is generated enzymatically from the terminal guanidinonitrogen of L-arginine by nitric oxide synthase (NOS). Despite intensive investigations, the role of NO -either as the primary product of the L-arginine/NOS pathway or provided from the NO donor sodium nitroprusside (SNP) -in carcinogenesis and tumour cell growth remains unclear and controversial. The objective of this study was to examine the growth effects of NO on a ductal pancreatic adenocarcinoma in the rat and on a human pancreatic tumour cell line were tested and related to growth (assessed by [3Hjthymidine incorporation assay) and apoptosis (assessed by intemucleosomal DNA cleavage). SNP exerted a dual effect on tumour cells: stimulation of the proliferation up to 1 mm and inhibition at higher concentrations. These effects were related to NO production. Both proliferative and cytostatic responses were inhibited by NO scavenger 2-phenyl-4,4,5,5-tetramethyl-hemidazoline-l-oxyl3-oxide (carboxy-PTIO). The marked apoptotic DNA fragmentation induced by SNP was also abolished by PTIO association. Unlike macrophages, the human pancreatic tumour cells did not seem to express intrinsicalty the L-arginine/NOS pathway. Macrophages were activated by HA-hpc2 cells as well as by LPS plus cytokines [interleukin (IL)-1 5 plus tumour necrosis factor (TNF)-ca and interferon (IFN)-y,. In HA-hpc/macrophage co-cultures. NOS activity and inducible NOS (iNOS) transcription were stimulated, whereas an antiproliferative response was observed. These effects were related to both macrophage amount and NO production. Addition of LPS plus cytokines to co-cultures doubled iNOS activity, nitrite/nitrate production and tumoricidal effect. These data suggest the involvement of NO in pancreatic tumour growth and support the fact that generation of high levels of NO with potential production of endogenous reactive nitrogen intermediates may contribute to induction of apoptosis and tumour growth inhibition.
relaxing factor (Palmer et al. 1987) . emerges as a strikino signal transduction molecule MN-olxed in a large xariety of pathophxsiological processes (Moncada et al. 1991) . NO is generated as a free radical through a NO sxnthase-mediated oxidation (requiring additional NADPH ( Gabott and Bacon. 1993 ) of the terminal cuanidine nitrogen of L-arginine. As demonstrated bx molecular cloning (Lams et al. 1992: Xie et al. 19921 . there are at least txo NO svnthase isoform classes: a constitutixve (cNOS) or Ca'--calmodulin-dependent one and an inducible (iNOS) or Ca'-independent one. even though this class has been show n to have a calmodulin binding site (Bredt and Snx der. 1990 : Moncada et al. 1991 . Prexalent in some cell txpes such as endothelial (eNOSI or neuron (nNOS) cells. cNOS isoforms are activated xia intracellular Ca' increase or physical stimulus. Requiring, calmodulin but not Ca'-increase for its acti'itx.iNOS generates negligible NO under basal conditions. Inducible in macrophages. hepatocytes. endothelial or X ascular smooth muscle cells. its transcription requires cytokine [interferon (IFN -y. tumour necrosis factor (TNF>-Ct and interleukin (IL (-I13] and/or endotoxin actixvation (Hibbs et al. 1987 : Stuehr and Marletta. 1987 : Lepoix-re et al. 1989 .
It has been long recognized that actix ated macrophages produce cvtotoxic or at least cytostatic effects on microbial pathogens and tumour cells (Weinberg et al. 1978 ) . Xia a release of both cvtokines and NO (Palmer et al. 1987 : Kuwon et al. 1990 : Hibbs. 1991 ). In addition. bacterial lipopolx saccharide (LPS) or cytokine iNOS activation induces macrophage NO sx nthesis (Stuehr and Marletta. 1987) . Acting as a powerful reducinc and oxidizing agyent able to donate and catch electrons (Beckman et al. 1990 . NO can interfere with iron-sulphur-containing enzymes ensuinLg iron release and inhibit both mitochondrial electron transport chain (Stuehr and Nathan. 19891 and ribonucleotide reductase actixitv (Lepoix-re et al. 1990 ). a rate-limitina step in DNA sxnthesis. As a matter of fact. the potential consequence of producing large amounts of NO mav be local cxtotoxicitx. As a radical. NO reacts with oxvLgen species and w-ater. formincg other tissue toxic Noxides such as peroxynitrite (Beckman et al. 1990: Esumi and Tannenbaum. 19941 . The role of NO and its closel1 related catabolic products such as NO-/NO-in the pathogyenesis of inflammation and tumour cell death or apoptosis (Nguxen et al. 1992: Esumi and Tannenbaum. 1994 can be explained this waxy. Excessix e NOS induction. leading to too large a quantitx of NO 841 production. has also been implicated in endothelial cell damage (Beckman et al. 1990 ). Accumulation of all these highly reactive compounds (NO radical. nitrite. nitrate. peroxynitrite and peroxynitrate) suggests potential genotoxic effects of NO in target cells (Nguyen et al. 1992) .
We have designed the present study to evaluate both the effect of pancreatic tumour cell growth inhibition by NO overproduction and the possible role of macrophage-derived NO in mediating tumoricidal activity in vivo and in vitro.
MATERIALS AND METHODS Media and ragents
NG-nitro L-arginine methyl ester (L-NAME). L-arginine and >-arginine hydrochlorides, sulphanilamide. N-(naphthyl)ethylenediamine dihydrochloride. FAD, lipopolysaccharide (LPS In vivo experiments Experimental animals Male Lewis rats (180-200g) and male C3H/HeN mice (6-10 weeks old) purchased from Charles River Laboratories (Orleans.
France) were maintained according to the guidelines for laboratory animal use and care with free access to tap water and standard specific chow.
Tumour system
The rat ductal pancreatic carcinoma is derived from a primary transplantable acinar carcinoma that was originally chemically induced by azaserine in Lewis rats (Pettengill et al, 1993) . Tumour cell preparation has been described previously (Hajri et al, 1992) . Briefly, tumour tissue from the donor rat was removed, washed in ice-cold Hank's balanced salt, sliced, passed through a no. 30 stainless-steel screen and centrifuged (500g). For tumour injection, the pellet was resuspended (v/v) in DMEM before cell count. Aliquots of approximately 150 jil of the final suspension of almost 5x106 cells were injected during laparotomy at a single site into the pancreas of 24 ketamin anaesthetized rats, as described elsewhere (Hajri et al, 1992) . Ten days later (a time interval for tumour to attain a volume of 0.3-0.5 cm3) rats were randomly allocated to four experimental groups of eight animals.
Experimental schedules
Animals were injected daily i.p. for 15 days with either 500 gi of sodium chloride solution (9 g 1-1) or 100 mg kg-' sodium nitroprusside, or 400 mg kg-' L-arginine monohydrochloride alone or added to 50 mg kg-' L-NAME. The last two groups also received a 3 mg kg-' endotoxin (LPS) i.p. injection at 5-day intervals. After euthanasia using an injectable agent (ketamine i.p. (1951) . Schneider (1957) and Richards (1974) No L-NAME + L-NAME NO L-NAME + L-NAME Values represent the means (::s.e.) of six experiments. Each well contains 5 x 10-cells in 1 ml of medium. Cytokines (IL-1i . IFN-y and TNF-a) were added to L-arg/LPS treatment (L-arginine and LPS stimulation). The NOS inhibitor (L-NAME) was tested on L-arg/LPS experiments. Statistical comparisons were done towards L-arginine control values (-p < 0.001. P < 0.01) and. when L-NAME treatment was applied. towards the corresponding L-arg/LPS group ( P < 0 01). and TNF-a) were added to co-culture medium. All the experiments were performed with and without the NOS inhibitor (L-NAME). For each macrophage concentration. statistical comparisons were done towards the corresponding L-arginine-no L-NAME control values (ap < 0.05. :P < 001. -P < 0.001).
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RESULTS

Modulation of pancreatic tumour growth in vivo by exogenous and endogenous NO
The most obvious chanae induced bv SNP and LPS treatments w as seen in tumour Xolumes (almost three times smaller than 'control ) and related to tumour masses (data not show-n ). The other grow-th parameters. expressed per g of wxet w-eight. w-ere slightly (almost 20c% decrease in protein and 30%c decrease in RNA contents) or not sigmificantlv affected (no chanae in DNA content). The addition of L-NANME did not suppress the inhibitorx effects of L-arginine and LPS (data not show-n I.
Exogenous NO effects on pancreatic tumour cell growth in vitro As illustrated in Figure 1 . increasing concentrations of SNP eave a dose-related release in nitnrte/nitrate (correlation coefficient r = 0.931. follow-ing an increasing logan'thmic pattern. The data of ['H]thy-midine incorporation in tumour cell DNA (Fig-ure 1) also show-ed a dose-related exponential rise (r = 1) up to a 0.5 nmi SNP. Figure 2B ). The typical tight confluent cobblestone appearance of pancreatic tumour cells in culture wvas still present in 0.5 rnm pretreated HA-hpc, cells (Figure 2A ). In 2.5 mm pretreated cells (Figure 2b ) cell confluence was not achieved and many floating cell clusters. sign of a cytotoxic effect. %vere obsen-ed.
The cytostatic effect of SNP concentrations higher than 1 mm w as not linked to a deleterious action of some breakdown products of SNP. The addition of the NO scavenger carboxy-PIlO inhibited the whole decrease in [FH] thymidine incorporation achieved with both 1.5 and 2.5 mm SNP (Figure 3) . The positive effect of SNP concentrations lower than 1 mm on proliferation of HA-hpc, cells was also inhibited by the addition of the NO scavenger carboxv-PTIO (Figure 3 ).
Endogenous NO induction and effects on macrophages in culture The effects of NO-inducing agents (LPS plus L-arginine and cvtokines) and of the NOS inhibitor (L-NAME) on macrophages are summanzed in Table 1 . As expected. LPS plus L-arginine drasticallI increased NO release to the cell culture medium (more than 13-fold). This NO production Was L-arginine dependent. as the use of E-arginine at the same concentration failed to generate NO (data not show n). The addition of cvtokines (IL-15. IFN-y and TNF-a) increased the release of NO bv 45%7c (P<0.001). The addition of L-NAME reduced these releases of NO slightl (almost 20%. Table 2 . According to our obser-vations (Table 1) . the concomitant addition of L-arginine plus LPS and cytokines to tu-ice the number of tumour cells did not affect NO release sirnificantly w hen macrophages w-ere missing but reduced tumour cell proliferation by 50%. L-NAME supply decreased partlv (almost In macrophage-tumour cell co-cultures. basic enzyme actixity was dramatically enhanced (30 times higher than in macrophage cultures). Further increases in NOS activity xvere induced bv LPS (+40%) and by LPS plus cytokine additions (+100%lc).
Inducible NO synthase gene transcription Intemucleosomal DNA cleavage by NO release in pancreatic ductal tumour cells Figure 5 (lanes 4-6) show s the typical DNA ladder fragmentation pattem in agreement w ith cell apopotosis. This pattem w as detected w-hen tumour cells w ere incubated 24 h in the presence of 1.5. 2.5 and 5 m-i of SNP. This degradation pattem was not observed when 24-h incubation was carried out with 0.5 mmol (or less) of SNP (lanes 2 and 3) . This pattern as also absent when the NO scavenger carboxv-WO was added to 1.5 mMf (Figure 6 . lanes 3 and 4) or 2.5 mn of SNP (Fiaure 6. lanes 6 and 7). DNA ladder fragmentation pattem did not appear when the pancreatic tumour cells were treated with a combination of L-arginlne. LPS and cytokines ( Figure 5. lane 7) .
Nitric oxide synthase activities
The lexvels of NOS actixitx in tumour cell cultures. macrophage cell cultures and tumour cell-macrophage co-cultures are summarized in Table 3 . In tumour cells. NOS activitx alwavs remained undetectable. exen after incubation with LPS and cvtokines. In macrophages. the inherent enzyme activityx as increased (almost six times) bv the addition of LPS. The cxtokine treatment increased NOS actixvity oxer twofold.
DISCUSSION
The pharmacological studies relating to the role of NO in mediating carcinogenesis and tumour growth haxe y-ielded controxersial results with regard to the kind of cancers and the design of the investioations (Hibbs. 1991 : Taniouchi et al. 1993 : Esumi and Tannenbaum. 1994 . In the present study wAe describe our attempt to evaluate the effect of high level of NO and of local NOS production on pancreatic tumour growth. (Laskin et al. 1995 (1998) 78(7). 841-849 from 0.1 up to 0.5 rnmi. whereas at higher concentrations an internucleosomal fragmentation pattern. characteristic of apopotosis induction. was present. These findings agree with the dual NO tumoricidal action. depending on the local concentration of the molecule suggested by Jenkins et al (1995) . The proliferative effect of NO. firmly established by its inhibition by the NO scavenger carboxy-PTIO. could be explained by the well-known involvement of cGMP in cell proliferation (Moncada et al. 1991) . The antiproliferative effect of NO is not related to breakdown products of SNP such as cyanide or ferrocyanide as the NO scavenger carboxy-PTIO clearly inhibited both the drop in [ H]thymidine incorporation and the tumour cell apoptosis induction. This cytotoxicity may be related to the yield of iron nitrosyl complexes. to the inhibition of mitochondrial respiration and DNA synthesis Nathan. 1989: Lepoivre et al. 1990 ). and to DNA damage (Henle and Linn. 1997: Ibuky and Goto. 1997) .
The pancreatic tumour cell line used (HA-hpc,) appeared unable to produce NO after endotoxin and cytokine treatents. Under the same experimental conditions. NO release from murine macrophages showed almost a 15-fold increase. It seems likely that iNOS gene expression is very weak in this pancreatic tumour cell line. Indeed the negative NOS assays were corroborated by the undetectable iNOS mRNA expression after RT-PCR. However. this result cannot be considered as true for all pancreatic cancers. A disparity in iNOS gene expression has been demonstrated in colon cancer cell lines (Jenkins et al. 1994) . Moreover. the in vivo overexpression of the iNOS gene in nonnal human airway epithelium disappeared in primary culture (Guo et al. 1996) . In our data. the antiproliferative effect of cytokines on pancreatic tumour cell cultures reflected a more than 50% drop in
[ H]thymidine incorporation in DNA. The anti-tumour effect we have observed in vivo with L-arginine/LPS treatment may be explained by the effect of cytokines released from endotoxin-activated immune cells. Thus. the tumoricidal effect of macrophages was investigated on HA-hpc, as target cells. In co-cultures. the influence of an increasing number of macrophages on NO biosynthesis was tested in relation to pancreatic tumour cell antiproliferative effect. Pancreatic tumour cells were able to activate macrophages without any stimulating factor. In the same way. Thomas et al (1995) reported that the CC531 colon adenocarcinoma cell line induced tumoricidal response of liver macrophages in vivo. This effect. apparent 1 day after inoculation of tumour cells in the liver. was still present after 4 weeks. As observed by these authors the tumoricidal response disappeared with a ten times higher tumour cell volume. Our results showing a tumoricidal efficiency dependent on macrophage density corroborate these findings. The fact that an immune cell infiltration of a tumour is not considered to be a good prognostic indicator of tumour growth seems to contradict these data. We can draw the hypothesis that these cells were not enough in number and/or are not fully activated. Indeed, the treatment of Lewis rats after pancreatic tumour allograft with LPS reduced drastically the tumour size. Similarly macrophage activation via LPS addition in co-culture fur-ther increased tumoricidal activity. as also observed by Thomas et al ( 1995) .
As this tumoricidal effect was not abrogated in the presence of NOS inhibitor. Thomas et al (1995) suggested that the tumoricidal response was not closely related to the production of reactive nitrogen intermediates. Our observations agree only in part with this hypothesis. If the NOS inhibitor used (L-NAME) significantly reversed part of the antiproliferative effects of unstimulated and stimulated macrophages. it was unable to abrogate the whole antiproliferative effect. This failure could be due to both a low specificity of this inhibitor and a relatively too high L-arginine supplem,entation. responsible for an unfavourable substrateinhibitor competition. A non-NO-dependent macrophage cytotoxicity cannot be discarded. But NO biosynthesis and antiproliferative effect were strongly correlated even after L-NAME addition. Overall, the implication of the L-arginineNOS pathway in the antiproliferative action of tumour-activated macrophages was corroborated by the investigations on iNOS gene expression. In macrophage-tumour cell co-cultures the enzyme activity of NOS was drastically increased (30 times higher than in macrophages alone), as was iNOS mRNA expression using RT-PCR assays.
We have also confirmed that the stimulation of the co-culture by LPS/cytokines further activated macrophages. with an increased NOS activity and a resulting increased NO biosynthesis responsible for almost 70% further drop in ["H]thymidine incorporation.
These results suggest that the antiproliferative effect of LPS/cytokines was linked to NO and nitrogen-reactive intermediate generation. which may act on tumour cells in a paracrine mode. This suggestion is in agreement with the report of an increased endogenous nitrate synthesis in patients receiving IL-2. demonstrating that a cytokine-inducible. high-output L-arginine/NOS pathway exists in human beings (Hibbs et al. 1992) .
The mechanism of macrophage activation by tumour cells is still unclear. In our experiments. as well as those of Thomas et al (1995) . there was close contact between the two kinds of cells. Using transwell cell co-culture systems will allow us to distinguish between contact or contingent paracrine activating factors.
Moreover, it will be better to test this activating process on syngenic cells since, as outlined by Adler et al (1996) . iNOS regulation in different species (human vs murine macrophages in our experiments) differs considerably. with large changes in iNOS gene expression in vitro (Jenkins et al. 1994 : Adler et al. 1996 : Guo etal. 1996 .
With an almost similar pattem of NO generation. SNP produced a dual proliferative and antiproliferative effect on tumour cells.
whereas activated macrophages induced a single antiproliferative response. It is clear that SNP spontaneously produces NO. which acts directly on tumour cells. In contrast. the cytotoxicity of macrophages is multifactorial. involving at least both an enzymatic process capable of inducing the production of NO and a release of numerous cytotoxic factors. In any case. NO seems to play a key role in the pancreatic tumour cell toxicity observed in our experiments. This cytotoxicity is probably linked to interactions between NO and some reactive oxygen intermediates such as superoxide anion. acting at several levels in the target cell (Beckman et al. 1990 : Nguyen et al. 1992 : Henle and Linn. 1997: Ibuki and Goto. 1977 ).
In conclusion, our expenrmental findings show that an antiproliferative effect was achieved on pancreatic adenocarcinoma both in vivo and in vitro by the means of either exogenous or endogenous NO generation. These NO-mediated cytostatic anti-tumour effects seem to be macrophage/cell-mediated immunity dependent and are increased by addition of cytokines and endotoxins. (1998) 78(7), [841] [842] [843] [844] [845] [846] [847] [848] [849] 0 Cancer Research Campaign 1998 ester. LPS. Iipopolysaccharide: NOS. nitric oxide synthase: SNP. sodium nitroprusside.
